Carboplatin binding to histidine

Lade...
Vorschaubild
Dateien
Tanley_0-258990.pdf
Tanley_0-258990.pdfGröße: 1.13 MBDownloads: 330
Datum
2014
Autor:innen
Tanley, Simon W. M.
Kroon-Batenburg, Loes M. L.
Levy, Colin
Schreurs, Aontoine M. M.
Helliwell, John R.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Acta Crystallographica Section F : Structural Biology and Crystallization Communications. 2014, 70(9), pp. 1135-1142. eISSN 1744-3091. Available under: doi: 10.1107/S2053230X14016161
Zusammenfassung

Carboplatin is a second-generation platinum anticancer agent used for the treatment of a variety of cancers. Previous X-ray crystallographic studies of carboplatin binding to histidine (in hen egg-white lysozyme; HEWL) showed the partial conversion of carboplatin to cisplatin owing to the high NaCl concentration used in the crystallization conditions. HEWL co-crystallizations with carboplatin in NaBr conditions have now been carried out to confirm whether carboplatin converts to the bromine form and whether this takes place in a similar way to the partial conversion of carboplatin to cisplatin observed previously in NaCl conditions. Here, it is reported that a partial chemical transformation takes place but to a transplatin form. Thus, to attempt to resolve purely carboplatin binding at histidine, this study utilized co-crystallization of HEWL with carboplatin without NaCl to eliminate the partial chemical conversion of carboplatin. Tetragonal HEWL crystals co-crystallized with carboplatin were successfully obtained in four different conditions, each at a different pH value. The structural results obtained show carboplatin bound to either one or both of the N atoms of His15 of HEWL, and this particular variation was dependent on the concentration of anions in the crystallization mixture and the elapsed time, as well as the pH used. The structural details of the bound carboplatin molecule also differed between them. Overall, the most detailed crystal structure showed the majority of the carboplatin atoms bound to the platinum centre; however, the four-carbon ring structure of the cyclobutanedicarboxylate moiety (CBDC) remained elusive. The potential impact of the results for the administration of carboplatin as an anticancer agent are described.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
carboplatin, histidine, avoid partial conversion to cisplatin, NaBr crystallization conditions, non-NaCl crystallization conditions, model protein (hen egg-white lysozyme)
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690TANLEY, Simon W. M., Kay DIEDERICHS, Loes M. L. KROON-BATENBURG, Colin LEVY, Aontoine M. M. SCHREURS, John R. HELLIWELL, 2014. Carboplatin binding to histidine. In: Acta Crystallographica Section F : Structural Biology and Crystallization Communications. 2014, 70(9), pp. 1135-1142. eISSN 1744-3091. Available under: doi: 10.1107/S2053230X14016161
BibTex
@article{Tanley2014Carbo-29341,
  year={2014},
  doi={10.1107/S2053230X14016161},
  title={Carboplatin binding to histidine},
  number={9},
  volume={70},
  journal={Acta Crystallographica Section F : Structural Biology and Crystallization Communications},
  pages={1135--1142},
  author={Tanley, Simon W. M. and Diederichs, Kay and Kroon-Batenburg, Loes M. L. and Levy, Colin and Schreurs, Aontoine M. M. and Helliwell, John R.}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29341">
    <dc:creator>Helliwell, John R.</dc:creator>
    <dc:contributor>Helliwell, John R.</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Schreurs, Aontoine M. M.</dc:creator>
    <dc:language>eng</dc:language>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/29341/1/Tanley_0-258990.pdf"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Diederichs, Kay</dc:creator>
    <dcterms:abstract xml:lang="eng">Carboplatin is a second-generation platinum anticancer agent used for the treatment of a variety of cancers. Previous X-ray crystallographic studies of carboplatin binding to histidine (in hen egg-white lysozyme; HEWL) showed the partial conversion of carboplatin to cisplatin owing to the high NaCl concentration used in the crystallization conditions. HEWL co-crystallizations with carboplatin in NaBr conditions have now been carried out to confirm whether carboplatin converts to the bromine form and whether this takes place in a similar way to the partial conversion of carboplatin to cisplatin observed previously in NaCl conditions. Here, it is reported that a partial chemical transformation takes place but to a transplatin form. Thus, to attempt to resolve purely carboplatin binding at histidine, this study utilized co-crystallization of HEWL with carboplatin without NaCl to eliminate the partial chemical conversion of carboplatin. Tetragonal HEWL crystals co-crystallized with carboplatin were successfully obtained in four different conditions, each at a different pH value. The structural results obtained show carboplatin bound to either one or both of the N atoms of His15 of HEWL, and this particular variation was dependent on the concentration of anions in the crystallization mixture and the elapsed time, as well as the pH used. The structural details of the bound carboplatin molecule also differed between them. Overall, the most detailed crystal structure showed the majority of the carboplatin atoms bound to the platinum centre; however, the four-carbon ring structure of the cyclobutanedicarboxylate moiety (CBDC) remained elusive. The potential impact of the results for the administration of carboplatin as an anticancer agent are described.</dcterms:abstract>
    <dc:creator>Levy, Colin</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Tanley, Simon W. M.</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/29341/1/Tanley_0-258990.pdf"/>
    <dc:contributor>Tanley, Simon W. M.</dc:contributor>
    <dc:contributor>Kroon-Batenburg, Loes M. L.</dc:contributor>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/29341"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-11-27T11:52:45Z</dcterms:available>
    <dcterms:title>Carboplatin binding to histidine</dcterms:title>
    <dc:creator>Kroon-Batenburg, Loes M. L.</dc:creator>
    <dc:contributor>Schreurs, Aontoine M. M.</dc:contributor>
    <dc:contributor>Levy, Colin</dc:contributor>
    <dcterms:issued>2014</dcterms:issued>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Diederichs, Kay</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-11-27T11:52:45Z</dc:date>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen